Results 291 to 300 of about 880,199 (399)
Should the Right Coronary Artery Be Routinely Assessed During Provocative Spasm Testing? [PDF]
Girolamo O +8 more
europepmc +1 more source
ABSTRACT Aortic regurgitation (AR) develops in up to 25%−30% of patients with left ventricular assist device (LVAD). Treatment remains challenging since surgery confers significant peri‐operative risk and the lack of valvular calcification renders transfemoral transcatheter aortic valve implantation (TF‐TAVI) with non‐dedicated devices technically ...
Daniel Tai‐Leung Chan +9 more
wiley +1 more source
Anomalous Origin of the Right Coronary Artery from the Left Main Coronary Artery in A Patient with Non-Specific Chest Pain. [PDF]
Soliman AF +5 more
europepmc +1 more source
ABSTRACT Background Intravascular lithotripsy (IVL) fractures calcified plaques and facilitates lesion expansion; however, unlike atherectomy devices, it does not reduce calcium volume. The therapeutic efficacy and safety of combining IVL with atherectomy remain unclear. Therefore, this study aimed to evaluate, through optical coherence tomography (OCT)
Marohito Nakata +3 more
wiley +1 more source
Case Report: A rare case of coronary artery anomaly (right coronary artery-pulmonary artery fistula with diffuse dilatation). [PDF]
Wang X, Yu J, Chen C, Yang Z, Yang L.
europepmc +1 more source
Chapter 4: Normal and Anomalous Coronary Arteries in Humans. Part 1: Historical Background [PDF]
Angelini, Paolo +3 more
core +1 more source
ABSTRACT With recent advances in endovascular therapy (EVT), treatment of complex peripheral artery disease, especially below‐the‐knee lesions, has become increasingly feasible using intravascular ultrasound (IVUS)‐guided techniques. However, reports on EVT for critical digital ischemia remain scarce because of its rarity.
Yasuyuki Tsuchida +6 more
wiley +1 more source
Impact of the Distance From the Cavotricuspid Isthmus to the Right Coronary Artery on First-Pass Conduction Block During Cryoablation for Atrial Flutter. [PDF]
Nodera M +5 more
europepmc +1 more source
Applying DanGer Shock Eligibility Criteria to a Real‐World Cohort of Cardiogenic Shock Patients
ABSTRACT Background The DanGer Shock trial investigated the effects of adding a microaxial flow pump to guideline‐recommended therapy in patients with ST‐elevation myocardial infarction (STEMI)‐related cardiogenic shock (CS), finding a lower all‐cause mortality at 180 days in the intervention group.
Raffaela Miriam Planka +14 more
wiley +1 more source

